Pfizer Inc

Northwest & Ethical Investments L.P. PFE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

416,062

Value ($000)

10,361

Weight

0.2%

2009 Q3 - 2025 Q4 (57 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	10,361	0.2%	416,062	12/31/2025
2025 Q3	11/12/2025	14,366	0.3%	564,657	9/30/2025
2025 Q2	8/13/2025	14,833	0.4%	611,943	6/30/2025
2025 Q1	5/13/2025	5,308	0.1%	209,453	3/31/2025
2024 Q4	2/11/2025	7,032	0.2%	265,072	12/31/2024
2024 Q3	11/14/2024	7,627	0.2%	263,531	9/30/2024
2024 Q2	8/14/2024	7,155	0.2%	255,732	6/30/2024
2024 Q1	7/9/2025	6,545	0.2%	235,850	3/31/2024
2023 Q4	7/9/2025	11,233	0.3%	390,179	12/31/2023
2023 Q3	7/9/2025	12,095	0.4%	364,646	9/30/2023
2023 Q2	7/9/2025	8,201	0.3%	223,588	6/30/2023
2023 Q1	7/9/2025	6,432	0.2%	157,647	3/31/2023
2022 Q4	7/9/2025	7,372	0.3%	143,880	12/31/2022
2022 Q3	7/9/2025	9,430	0.4%	215,500	9/30/2022
2022 Q2	7/9/2025	10,771	0.4%	205,429	6/30/2022
2022 Q1	7/9/2025	6,544	0.2%	126,402	3/31/2022
2021 Q4	7/9/2025	10,723	0.3%	181,583	12/31/2021
2021 Q3	7/9/2025	3,028	0.1%	70,405	9/30/2021
2021 Q2	7/9/2025	2,126	0.1%	54,294	6/30/2021
2021 Q1	7/9/2025	4,661	0.2%	128,664	3/31/2021
2020 Q4	7/8/2025	3,260	0.1%	88,550	12/31/2020
2020 Q3	7/8/2025	3,471	0.2%	94,567	9/30/2020
2020 Q2	7/8/2025	3,128	0.1%	95,670	6/30/2020
2020 Q1	7/8/2025	2,985	0.2%	91,458	3/31/2020
2019 Q4	7/8/2025	6,509	0.3%	166,139	12/31/2019
2019 Q3	7/8/2025	3,466	0.2%	96,477	9/30/2019
2019 Q2	7/8/2025	4,002	0.2%	92,376	6/30/2019
2019 Q1	7/8/2025	7,453	0.4%	175,488	3/31/2019
2018 Q4	7/8/2025	7,399	0.4%	169,509	12/31/2018
2018 Q3	7/8/2025	6,585	0.4%	149,429	9/30/2018
2018 Q2	7/8/2025	5,340	0.4%	147,179	6/30/2018
2018 Q1	7/8/2025	3,547	0.2%	99,955	3/31/2018
2017 Q4	7/8/2025	2,180	0.1%	60,189	12/31/2017
2017 Q3	7/8/2025	2,363	0.1%	65,779	9/30/2017
2017 Q2	7/8/2025	2,066	0.1%	61,509	6/30/2017
2017 Q1	7/8/2025	2,298	0.2%	67,169	3/31/2017
2016 Q4	7/8/2025	1,697	0.1%	52,259	12/31/2016
2016 Q3	7/8/2025	5,421	0.4%	160,050	9/30/2016
2015 Q1	7/8/2025	5,462	0.4%	157,000	3/31/2015
2014 Q4	7/8/2025	4,934	0.3%	158,400	12/31/2014
2013 Q3	7/8/2025	11,665	0.8%	406,290	9/30/2013
2013 Q2	7/8/2025	10,831	0.8%	386,675	6/30/2013
2013 Q1	7/8/2025	12,316	0.9%	426,740	3/31/2013
2012 Q4	7/7/2025	9,544	0.8%	380,560	12/31/2012
2012 Q3	7/7/2025	9,984	0.9%	401,775	9/30/2012
2012 Q2	7/7/2025	18,360	1.9%	798,245	6/30/2012
2012 Q1	7/7/2025	13,942	1.3%	615,250	3/31/2012
2011 Q4	7/7/2025	12,539	1.3%	579,445	12/31/2011
2011 Q3	7/7/2025	10,671	1.1%	603,555	9/30/2011
2011 Q2	7/7/2025	12,126	1.0%	588,655	6/30/2011
2011 Q1	7/7/2025	11,064	0.9%	544,775	3/31/2011
2010 Q4	7/7/2025	9,757	0.8%	557,235	12/31/2010
2010 Q3	7/7/2025	9,123	0.8%	531,350	9/30/2010
2010 Q2	7/7/2025	7,456	0.8%	522,850	6/30/2010
2010 Q1	7/7/2025	7,853	0.7%	457,900	3/31/2010
2009 Q4	7/7/2025	8,027	0.8%	441,300	12/31/2009
2009 Q3	7/7/2025	8,015	0.8%	484,300	9/30/2009